CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $18,000 | -14.3% | 401 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $21,000 | -40.0% | 401 | -23.2% | 0.00% | 0.0% |
| Q4 2017 | $35,000 | -16.7% | 522 | +2.0% | 0.00% | 0.0% |
| Q3 2017 | $42,000 | -10.6% | 512 | +2.2% | 0.00% | -50.0% |
| Q2 2017 | $47,000 | +46.9% | 501 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $32,000 | +77.8% | 501 | +21.9% | 0.00% | 0.0% |
| Q4 2016 | $18,000 | -91.5% | 411 | -96.0% | 0.00% | -80.0% |
| Q3 2012 | $211,000 | -5.4% | 10,300 | 0.0% | 0.01% | -16.7% |
| Q2 2012 | $223,000 | -14.9% | 10,300 | 0.0% | 0.01% | -14.3% |
| Q1 2012 | $262,000 | – | 10,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |